CAAS Capital Management’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding OPTN
PCMI
RHJA
OM
WA
CAAS Capital Management's OPTN Position: Q1 2021 in Review
CAAS Capital Management sold out of OptiNose (OPTN) in Q1 2021, closing a stake of 13,870 shares — an estimated $861K sold.
CAAS Capital Management first reported a position in OPTN in Q1 2020 and held it in 3 quarters. The position peaked at $1.52M in Q3 2020. 68 funds tracked by Wall St. Rank hold OPTN as of Q1 2021.
- CAAS Capital Management reported no remaining OptiNose position as of Q1 2021 after selling out during the quarter.
- CAAS Capital Management sold 13,870 OptiNose shares in Q1 2021, an estimated $861K.
- CAAS Capital Management first reported a position in OptiNose in Q1 2020 and held it in 3 quarters.
- CAAS Capital Management's OptiNose position peaked at $1.52M in Q3 2020.
- 68 funds tracked by Wall St. Rank held OptiNose as of Q1 2021.
Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.